Adage Capital Partners’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $97.6M | Buy |
15,016,500
+2,500,000
| +20% | +$16.3M | 0.16% | 120 |
|
|
2025
Q1 | $101M | Buy |
12,516,500
+2,894,396
| +30% | +$23.4M | 0.19% | 109 |
|
|
2024
Q4 | $119M | Sell |
9,622,104
-81,247
| -0.8% | -$1.01M | 0.21% | 91 |
|
|
2024
Q3 | $79.6M | Buy |
9,703,351
+4,345,632
| +81% | +$35.6M | 0.14% | 147 |
|
|
2024
Q2 | $26.7M | Buy |
5,357,719
+156,330
| +3% | +$780K | 0.05% | 363 |
|
|
2024
Q1 | $32.1M | Sell |
5,201,389
-786,341
| -13% | -$4.85M | 0.06% | 337 |
|
|
2023
Q4 | $30.2M | Buy |
5,987,730
+2,200,000
| +58% | +$11.1M | 0.06% | 317 |
|
|
2023
Q3 | $21.8M | Sell |
3,787,730
-831,179
| -18% | -$4.78M | 0.05% | 372 |
|
|
2023
Q2 | $16.8M | Hold |
4,618,909
| – | – | 0.04% | 460 |
|
|
2023
Q1 | $20M | Sell |
4,618,909
-907,975
| -16% | -$3.93M | 0.04% | 413 |
|
|
2022
Q4 | $38.7M | Buy |
5,526,884
+4,125,495
| +294% | +$28.9M | 0.09% | 253 |
|
|
2022
Q3 | $5.06M | Sell |
1,401,389
-1,345,752
| -49% | -$4.86M | 0.01% | 779 |
|
|
2022
Q2 | $8.93M | Buy |
2,747,141
+2,297,141
| +510% | +$7.47M | 0.02% | 697 |
|
|
2022
Q1 | $900K | Hold |
450,000
| – | – | ﹤0.01% | 939 |
|
|
2021
Q4 | $1.41M | Buy |
450,000
+50,000
| +13% | +$157K | ﹤0.01% | 884 |
|
|
2021
Q3 | $1.96M | Buy |
+400,000
| New | +$1.96M | ﹤0.01% | 895 |
|